PCSK9 and coronary artery disorder: As we have learned, the IVW approach’s findings demonstrated that PCSK9 inhibitors considerably lowered the risk of CHD (OR: 0.349, 95% CI 0.121–0.578, P = 2.447 × 10− 19).